Possible Drug-Associated Sialolithiasis by the Bicarbonate Anhydrase Inhibitor Topiramate: A Case Report and Literature Review

Abstract Topiramate is an antiepileptic drug indicated for the treatment of seizure disorders, migraine prophylaxis, and more recently, for weight loss. This new indication will likely increase use of this agent significantly. As a carbonic anhydrase inhibitor, topiramate can affect the pH of bodily...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of oral and maxillofacial surgery
Main Authors:	Buhler, Amber V.K., Ph.D, Huynh, Pearl, Pharm.D, Low, Pauline, Pharm.D., MSc, Von, Mary, DHEd., PA-C
Format:	Journal Article
Language:	English
Published:	2016
Subjects:	Surgery
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract Topiramate is an antiepileptic drug indicated for the treatment of seizure disorders, migraine prophylaxis, and more recently, for weight loss. This new indication will likely increase use of this agent significantly. As a carbonic anhydrase inhibitor, topiramate can affect the pH of bodily fluids, and is known to increase risk of nephrolithiasis. However, as discussed here, these properties also result in an as so far unaddressed risk for development of sialoliths, calcified stones formed in the salivary duct or glands. The physiological mechanisms for stone development in the salivary gland are reviewed, and the pharmacological effects of topiramate on sialolith formation are discussed. This report describes a female patient treated with topiramate for migraine prophylaxis who subsequently presented with a sialolith in the left submandibular duct.
ISSN:	0278-2391
DOI:	10.1016/j.joms.2016.05.011